Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.

Antiviral therapy - 1 Jan 2014

Tseng Kuo-Chih, Chen Chi-Yi, Tsai Hung-Wen, Chang Ting-Tsung, Chuang Wan-Long, Hsu Ping-I, Liu Wen-Chun, Cheng Pin-Nan

Abstract excerpt

BACKGROUND: It is still inconclusive whether chronic hepatitis B (CHB) patients with persistently normal alanine aminotransferase (PNALT) should receive nucleoside/nucleotide analogues. This study is to evaluate the efficacy of entecavir in improving liver histology in CHB patients with PNALT. METHODS: In this prospective randomized, double-blind, placebo-controlled study, 380 CHB patients with PNALT were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Guanine

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Viral Load

Source

Identifiers

PMID: 24583931
DOI: 10.3851/IMP2754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.PMID 24583931Read ↗

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.Semantic proximity Read ↗

Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.Semantic proximity Read ↗

Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.Semantic proximity Read ↗

Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients.Semantic proximity Read ↗

Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry.Semantic proximity Read ↗

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.Semantic proximity Read ↗

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failureSemantic proximity Read ↗

Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.Semantic proximity Read ↗

Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.Semantic proximity Read ↗

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionSemantic proximity Read ↗

Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results.Semantic proximity Read ↗

Active disease in chronic hepatitis C patients with normal alanine aminotransferase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.